Careers | Media | Investors | Consumers | Healthcare professionals | B2B | Select country Home Explore GSK Research Partnerships Responsibility Products About us We are dedicated to improving the quality of human life by enabling people to do more, feel better and live longer. Read our story Research Trial data and open innovation Explore GSK Neuroscience: on the brain News China investigation Careers Why work with us? Explore GSK Our vaccines strategy - how we're improving access Products Information on our products Investors Q3 2013 results announcement News GSK announces changes to its global sales and marketing practices to further ensure patient interests come first Previous 1 2 3 Next Our news These press releases are intended for business journalists and analysts/investors. 24 January 2014 GSK announces headline results for Phase III study of the combination of Tafinlar® (dabrafenib) and Mekinist® (trametinib) in metastatic melanoma 24 January 2014 GSK receives positive opinion from the CHMP in Europe for once-weekly EperzanTM (albiglutide) for the treatment of type 2 diabetes 21 January 2014 ViiV Healthcare’s new HIV medicine TivicayTM (dolutegravir) is approved in Europe View all corporate press releases Join the conversation Follow us on Twitter Like us on Facebook Watch us on YouTube Visit us on Flickr Follow us on LinkedIn Your career at GSK Looking for a new job? Find out about working at GSK and how to apply for a job. What we do Why GSK? Experienced professionals View our careers section Explore our products We make and market a wide range of prescription medicines, vaccines and consumer healthcare products.To find a product, visit our products page or click on a link below. Our consumer healthcare products We bring dental health products, over-the-counter medicines and nutritional drinks to millions of people. GSK in the USA US corporate website US media and news Transparency reporting Work at GSK Share price Investors Investing in GSK Share price analysis View our investors section Clinical data Clinical Study Register Paroxetine and adult patients Paroxetine and pregnancy Paroxetine - paediatric and adolescent patients Sitemap / Terms of use / Accessibility / Cookie policy / Privacy / Policies, codes and standards / GSK employees / Contact us Page updated on Thursday 05 December 2013 © 2001-2014 GlaxoSmithKline plc. All rights reserved. Registered in England and Wales No. 3888792. Registered office: 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom.